Directory
>
Michelle Gee
Michelle Gee
Director, Development Sciences, Neurosciences Medicines Development Centre | Eisai US
United Kingdom
Michelle Gee
Summary
Michelle Gee is an accomplished Executive Director specializing in Clinical Development for Alzheimer's Disease and Brain Health at Eisai, with over 25 years of experience in the pharmaceutical industry. She has a robust background in clinical research, particularly in Phase II and Phase III trials within the Neuroscience therapeutic area. Michelle has authored multiple clinical documents, demonstrating her expertise in regulatory submissions and compliance with ethics committees. Known for her strong leadership skills, she excels in motivating cross-functional teams and managing stakeholder relationships. Her analytical mindset and attention to detail enable her to navigate complex data effectively. A graduate of the University of Bristol and University College London, she holds a BSc and a PhD in Physiology. Michelle's passion for advancing clinical research is evident in her commitment to improving patient outcomes in challenging therapeutic areas.
Michelle Gee
Work Experience
Executive Director, Clinical Development, Alzheimer's Disease and Brain Health at
Eisai US
February 2011 - Present
Michelle Gee
Education
University of Bristol, BSc Hons, Physiology
January 1990 - January 1993
University College London, PhD, Physiology
January 1993 - January 1996
Frequently Asked Questions about Michelle Gee
What is Michelle Gee email address?
Michelle Gee's primary email address is ************@eisai.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Michelle Gee work for?
Michelle Gee is a Director, Development Sciences, Neurosciences Medicines Development Centre at Eisai US.
Where Michelle Gee graduated from?
Michelle Gee holds a degree in from University of Bristol.
How can I directly contact Michelle Gee?
To contact Michelle Gee directly, you can use the email address ************@eisai.com. Complete contact information is available upon registration with Muraena.
Who is Michelle Gee?
Michelle Gee is an accomplished Executive Director specializing in Clinical Development for Alzheimer's Disease and Brain Health at Eisai, with over 25 years of experience in the pharmaceutical industry. She has a robust background in clinical research, particularly in Phase II and Phase III trials within the Neuroscience therapeutic area. Michelle has authored multiple clinical documents, demonstrating her expertise in regulatory submissions and compliance with ethics committees. Known for her strong leadership skills, she excels in motivating cross-functional teams and managing stakeholder relationships. Her analytical mindset and attention to detail enable her to navigate complex data effectively. A graduate of the University of Bristol and University College London, she holds a BSc and a PhD in Physiology. Michelle's passion for advancing clinical research is evident in her commitment to improving patient outcomes in challenging therapeutic areas.
Michelle`s contact details
************@eisai.com
Colleagues
Clinical Psychiatry, Neuropsychiatry, Neurology and Neuroscience Research Rotations
Manager, SAS Clinical Programming; Sr Clinical SAS Programmer; Clinical Data Manager
Executive Sales Representative
Market Analyst
Sales
Researcher
Project/Program Manager
Associate Director
Director US Compensation & Benefits
Postdoctoral fellow